Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Merck KGaA hands over CAR-T therapy business to Intrexon in deal worth $175 million

pharmafileDecember 24, 2018

Tag: Merck KGaA , Intrexon , CAR-T

PharmaSources Customer Service